|
hallo dosto, good news zu ivax: 8:43am 10/22/01 Ivax highlights generic cancer drug (IVX, BMY) By Ted Griffith Ivax Corp. said Monday that patient testing indicated its generic cancer drug was as effective, or more effective, than its branded competitor, Taxol, made by Bristol-Myers Squibb. Ivax also said its drug, called Paxoral, didn`t have the "inconvenience and side effects of the prolonged infusions and pre-medications associated with Taxol." Ahead of the announcement, shares of Ivax (IVX) fell $1.20 to $19.90 while shares of Bristol-Myers (BMY) dipped 53 cents to $58.23. grüsse cabinda |
|
| aus der Diskussion: | generics |
| Autor (Datum des Eintrages): | cabinda (22.10.01 16:29:37) |
| Beitrag: | 27 von 125 (ID:4692069) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |